Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability Enhancement

Risedronate-loaded mPEG-coated hydroxyapatite, thiolated chitosan-based (coated) and non-coated nanoparticles were tested for their potential effects in the treatment of osteoporosis. The prepared nanoparticles were evaluated for their bone-targeting potential by inducing osteoporosis in female Wist...

Descripción completa

Detalles Bibliográficos
Autores principales: Saifi, Zoya, Shafi, Sadat, Ralli, Tanya, Jain, Shreshta, Vohora, Divya, Mir, Showkat Rasool, Alhalmi, Abdulsalam, Noman, Omar M., Alahdab, Ahmad, Amin, Saima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534762/
https://www.ncbi.nlm.nih.gov/pubmed/37765307
http://dx.doi.org/10.3390/pharmaceutics15092339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534762/
https://www.ncbi.nlm.nih.gov/pubmed/37765307
http://dx.doi.org/10.3390/pharmaceutics15092339

Ejemplares similares